Article
Long-term all-cause mortality of metabolic-dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study.
Diabetes, obesity & metabolism - 1 Feb 2025
Koh Jaycie, Mohamed Ayman, Kong Gwyneth, Wong Esther, Chen Yiming, Anand Vickram Vijay, Chong Bryan, Chin Yip Han, Wang Jiong-Wei, Khoo Chin Meng, Chan Siew Pang, Muthiah Mark, Dimitriadis Georgios K, Chan Mark Yan-Yee, Loh Poay-Huan, Chew Nicholas W S
Abstract excerpt
OBJECTIVE: Metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity increases risk of cardiovascular disease. This cohort study examines the prognostic value of MASLD, across body weight categories, in a secondary preventative acute myocardial infarction (AMI) cohort. METHODS: Patients with AMI were stratified into four phenotypes-obesity MASLD, non-obesity MASLD, obesity non-MASLD,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.